FDA Approved: ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE — Original Application (AvKARE)

View source ↗

Summary

The FDA approved AvKARE's aspirin and extended-release dipyridamole as an original-application product (ANDA). It is indicated to reduce the risk of stroke in p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Transient Ischemic Attack

Drugs mentioned

• Aspirin and extended-release dipyridamole (Aspirin and extended-release dipyridamole)

Snippet

ORIG AP for ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE (ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE)